Brief: Transgene And BioInvent Enrol First Patient In Phase I/IIa Of Oncolytic Virus BT-001 Trial

Transgene SA

01/03/2021 07:11

March 1 (Reuters) - BIOINVENT INTERNATIONAL AB  BINV.ST :
    * TRANSGENE AND BIOINVENT HAVE ENROLLED FIRST PATIENT IN
PHASE
I/IIA TRIAL OF NOVEL ONCOLYTIC VIRUS BT-001 IN SOLID TUMORS

Source text for Eikon:  ID:nBwb1RCm7a 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))